Prof. Dr. Artur Mazur is a Full Professor at the University of Rzeszów and also a Vice-Rector for the Medical College of the University of Rzeszów. He obtained a Ph.D. from the Faculty of Medicine of the Medical University of Silesia in Katowice. For many years, he has been conducting research on endocrinology and diabetes in children, rare and very rare diseases in children in the Podkarpackie Voivodeship, and the role of nutrition in public health.
Strategic Advisory Group
The European Academy of Paediatrics (EAP) is the body of the UEMS (European Union of Medical specialists) which strives to promote the health of children and adolescents in Europe; one of its main mission is to secure adequate training of paediatric specialists. Around five years ago, the EAP has established a new strategic advisory group on adolescent medicine and health whose mission is to support initiatives in the field in setting up training initiatives and publishing recommendations for the health care of young people. There are many reasons that have led to the decision to have this advisory group.
Multidisciplinary Joint Committee on Adolescent Medicine and Health
Training objectives for UEMS specialists pertaining to the care of adolescents and young adults
References website adolescent advisory group EAP
Adol advisory group EAP 2018 survey on training in adolescent health & medicine
Rare Diseases The Child and The United Nations SDG3
Patient Solidarity Day
Health for all begins with health literacy
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.